List of SBIR/STTR awards granted to Sinopia Biosciences, Inc.
Sinopia Biosciences, Inc. Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Sinopia Biosciences, Inc. in February, 2021 for $1,335,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM130268-02 | Phase II | 1,335,997 | February 5, 2021 | |||||||
A SBIR Phase II contract was awarded to Sinopia Biosciences, Inc. in May, 2019 for $802,538.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM121117-02 | Phase II | 802,538 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Sinopia Biosciences, Inc. in September, 2018 for $442,427.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM130268-01 | Phase I | 442,427 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Sinopia Biosciences, Inc. in April, 2019 for $224,284.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL146014-01A1 | Phase I | 224,284 | April 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Sinopia Biosciences, Inc. in September, 2021 for $577,562.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44NS124398-01 | Phase I | 577,562 | September 30, 2021 | |||||||
A SBIR Phase I contract was awarded to Sinopia Biosciences, Inc. in September, 2022 for $318,284.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DE031464-01A1 | Phase I | 318,284 | September 20, 2022 | |||||||
A SBIR Phase I contract was awarded to Sinopia Biosciences, Inc. in August, 2015 for $223,582.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL127843-01A1 | Phase I | 223,582 | August 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Sinopia Biosciences, Inc. in September, 2016 for $190,634.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM121117-01 | Phase I | 190,634 | September 15, 2016 | |||||||
A SBIR Phase II contract was awarded to Sinopia Biosciences, Inc. in June, 2017 for $1,527,749.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL127843-02 | Phase II | 1,527,749 | June 15, 2017 | |||||||
A SBIR Phase II contract was awarded to Sinopia Biosciences, Inc. in August, 2016 for $1,472,641.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL123074-02 | Phase II | 1,472,641 | August 15, 2016 | |||||||
A SBIR Phase I contract was awarded to Sinopia Biosciences, Inc. for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL123074-01 | Phase I | 150,000 | ||||||||
A SBIR Phase II contract was awarded to Sinopia Biosciences, Inc. in March, 2023 for $1,561,760.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44NS124398-02 | Phase II | 1,561,760 | March 1, 2023 |
